Cargando…

The Potential Roles of Exosomes Carrying APP and Tau Cleavage Products in Alzheimer’s Disease

Alzheimer’s disease (AD) is the leading cause of dementia throughout the world. It is characterized by major amyloid plaques and neurofibrillary tangles (NFTs), which are composed of amyloid-β (Aβ) peptide and hyperphosphorylated Tau (p-Tau), respectively. Exosomes, which are secreted by cells, are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yanfang, Gu, Yujin, Zhang, Qili, Liu, Hongliang, Liu, Yingying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003549/ https://www.ncbi.nlm.nih.gov/pubmed/36902671 http://dx.doi.org/10.3390/jcm12051883

Ejemplares similares

Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer’s disease
por: Zhang, Zhentao, et al.
Publicado: (2014)

NGF controls APP cleavage by downregulating APP phosphorylation at Thr668: relevance for Alzheimer's disease
por: Triaca, Viviana, et al.
Publicado: (2016)

Delta-secretase cleavage of Tau mediates its pathology and propagation in Alzheimer’s disease
por: Kang, Seong Su, et al.
Publicado: (2020)

Altered succinylation of mitochondrial proteins, APP and tau in Alzheimer’s disease
por: Yang, Yun, et al.
Publicado: (2022)

Facilitation of glutamate, but not GABA, release in Familial Alzheimer's APP mutant Knock‐in rats with increased β‐cleavage of APP
por: Tambini, Marc D., et al.
Publicado: (2019)

Aβ and Tau Regulate Microglia Metabolism via Exosomes in Alzheimer’s Disease
por: Zhao, Yuanxin, et al.
Publicado: (2022)

Nuclear Tau and Its Potential Role in Alzheimer’s Disease
por: Bukar Maina, Mahmoud, et al.
Publicado: (2016)

Zinc Overload Enhances APP Cleavage and Aβ Deposition in the Alzheimer Mouse Brain
por: Wang, Chun-Yan, et al.
Publicado: (2010)

The functions of long non-coding RNAs in neural stem cell proliferation and differentiation
por: Zhao, Yanfang, et al.
Publicado: (2020)

Peptide Interference with APP and Tau Association: Relevance to Alzheimer’s Disease Amelioration
por: Maron, Ruth, et al.
Publicado: (2020)

Preferential Regulation of Γ‐Secretase‐Mediated Cleavage of APP by Ganglioside GM1 Reveals a Potential Therapeutic Target for Alzheimer's Disease
por: Wang, Xiaotong, et al.
Publicado: (2023)

Nucleic acids and proteins carried by exosomes from various sources: Potential role in liver diseases
por: Xie, Danna, et al.
Publicado: (2022)

The role of exosomes in the pathogenesis of Alzheimer’ disease
por: Xiao, Tingting, et al.
Publicado: (2017)

Novel role of APP cleavage by ADAM10 for breast cancer metastasis
por: Wozniak, Justyna, et al.
Publicado: (2018)

Exosomal tau with seeding activity is released from Alzheimer’s disease synapses, and seeding potential is associated with amyloid beta
por: Miyoshi, Emily, et al.
Publicado: (2021)

CIP2A Causes Tau/APP Phosphorylation, Synaptopathy, and Memory Deficits in Alzheimer’s Disease
por: Shentu, Yang-Ping, et al.
Publicado: (2018)

BMP4 overexpression induces the upregulation of APP/Tau and memory deficits in Alzheimer’s disease
por: Zhang, Xiaoqing, et al.
Publicado: (2021)

Modeling Alzheimer’s Disease by Induced Pluripotent Stem Cells Carrying APP D678H Mutation
por: Chang, Kuo-Hsuan, et al.
Publicado: (2018)

Effect of Presenilin Mutations on APP Cleavage; Insights into the Pathogenesis of FAD
por: Li, Nuomin, et al.
Publicado: (2016)

Use of exosomes as vectors to carry advanced therapies
por: Sancho-Albero, María, et al.
Publicado: (2020)

Hyperphosphorylation and Cleavage at D421 Enhance Tau Secretion
por: Plouffe, Vanessa, et al.
Publicado: (2012)

Lysosomal Dysfunction Promotes Cleavage and Neurotoxicity of Tau In Vivo
por: Khurana, Vikram, et al.
Publicado: (2010)

Swedish mutant APP-based BACE1 binding site peptide reduces APP β-cleavage and cerebral Aβ levels in Alzheimer’s mice
por: Li, Song, et al.
Publicado: (2015)

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
por: Wu, Moxin, et al.
Publicado: (2021)

Immunosuppressive Protein Signatures Carried by Syncytiotrophoblast-Derived Exosomes and Their Role in Human Pregnancy
por: Mincheva-Nilsson, Lucia
Publicado: (2021)

NRF2 deficiency replicates transcriptomic changes in Alzheimer's patients and worsens APP and TAU pathology
por: Rojo, Ana I., et al.
Publicado: (2017)

Characterization of an APP/tau rat model of Alzheimer’s disease by positron emission tomography and immunofluorescent labeling
por: Filip, Thomas, et al.
Publicado: (2021)

CircRNA-ceRNA Network Revealing the Potential Regulatory Roles of CircRNA in Alzheimer’s Disease Involved the cGMP-PKG Signal Pathway
por: Zhang, Yuan, et al.
Publicado: (2021)

PHF-Core Tau as the Potential Initiating Event for Tau Pathology in Alzheimer’s Disease
por: Luna-Viramontes, Nabil Itzi, et al.
Publicado: (2020)

Tau Cleavage Contributes to Cognitive Dysfunction in Strepto-Zotocin-Induced Sporadic Alzheimer’s Disease (sAD) Mouse Model
por: Latina, Valentina, et al.
Publicado: (2021)

Nucleic acids and proteins carried by exosomes of different origins as potential biomarkers for gynecologic cancers
por: Ye, Miaomiao, et al.
Publicado: (2021)

Nucleic acids and proteins carried by exosomes of different origins as potential biomarkers for gynecologic cancers
por: Ye, Miaomiao, et al.
Publicado: (2022)

TREM2 and microglia exosomes: a potential highway for pathological tau
por: Jain, Nimansha, et al.
Publicado: (2022)

Beneficial Effect of Antibodies against β- Secretase Cleavage Site of App on Alzheimer’s-Like Pathology in Triple-Transgenic Mice
por: Rabinovich-Nikitin, Inna, et al.
Publicado: (2012)

The Role of Protein Misfolding and Tau Oligomers (TauOs) in Alzheimer’s Disease (AD)
por: Mroczko, Barbara, et al.
Publicado: (2019)

An App knock-in rat model for Alzheimer’s disease exhibiting Aβ and tau pathologies, neuronal death and cognitive impairments
por: Pang, Keliang, et al.
Publicado: (2021)

Tau Ubiquitination in Alzheimer's Disease
por: Li, Longfei, et al.
Publicado: (2022)

CRISPR/Cas9 editing of APP C-terminus attenuates β-cleavage and promotes α-cleavage
por: Sun, Jichao, et al.
Publicado: (2019)

Tau Protein Mediates APP Intracellular Domain (AICD)-Induced Alzheimer’s-Like Pathological Features in Mice
por: Ghosal, Kaushik, et al.
Publicado: (2016)

Microvesicles from cerebrospinal fluid of patients with Alzheimer’s disease display reduced concentrations of tau and APP protein
por: Spitzer, Philipp, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_usiprhv43r4fqtotjg8m6cpi80